Literature DB >> 27485363

Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials.

Sadeq Ali-Hasan-Al-Saegh1, Seyed Jalil Mirhosseini1, Zahra Ghodratipour1, Zahra Sarrafan-Chaharsoughi1, Elham Rahimizadeh1, Ali Akbar Karimi-Bondarabadi1, Fatemeh Haddad2, Arezoo Shahidzadeh1, Parisa Mahdavi1, Ali-Mohammad Dehghan1, Mahbube Tahernejad1, Azadeh Shahidzadeh1, Hamidreza Dehghan1, Azam Ghanei1, Mohammadreza Lotfaliani1, Alexander Weymann3,4, Mohamed Zeriouh3, Aron-Frederik Popov3, Anton Sabashnikov3.   

Abstract

This systematic review with meta-analysis sought to determine the strength of evidence for the effects of hydration (sodium bicarbonate [SB] and normal saline [NS]), supplementations ( N-acetylcysteine [NAC] and vitamin C), and some common drugs (adenosine antagonists [AAs], statins, loop diuretics, and angiotensin-converting enzyme inhibitors [ACEIs]) on the incidence of contrast-induced nephropathy (CIN) and requirement for hemodialysis after coronary angiography. After screening, a total of 125 trials that reported outcomes were identified. Pooled analysis indicated beneficial effects of SB versus NS (odds ratio [OR] = 0.73; 95% confidence interval [CI]: 0.56-0.94; P = .01), NAC (OR = 0.79; 95% CI: 0.70-0.88; P = .001), vitamin C (OR = 0.64; 95% CI: 0.45-0.89; P = .01), statins (OR = 0.45; 95% CI: 0.35-0.57; P = .001), AA (OR = 0.28; 95% CI: 0.14-0.47; P = .001), loop diuretics (OR = 0.97; 95% CI: 0.33-2.85; P = .9), and ACEI (OR = 1.06; 95% CI: 0.69-1.61; P = .8). Overall, hydration with SB, use of supplements, such as NAC and vitamin C, and administration of statins and AA should always be considered for the prevention of CIN after coronary angiography.

Entities:  

Keywords:  N-acetylcysteine; adenosine antagonist; angiotensin-converting enzyme inhibitors; antioxidants; contrast-induced nephropathy; hydration; loop diuretics; normal saline; sodium bicarbonate; statins; vitamin C

Mesh:

Substances:

Year:  2016        PMID: 27485363     DOI: 10.1177/0003319716661445

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  9 in total

1.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

2.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

3.  Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.

Authors:  Beibei Han; Yongguang Li; Zhifeng Dong; Qing Wan; Hong Shen; Jingbo Li; Meng Wei; Chengxing Shen
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

4.  Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants.

Authors:  Yaeko Hara; Hiroshi Sakagami; Haixia Shi; Tomoyuki Abe; Nobuaki Tamura; Hiroshi Takeshima; Norio Horie; Takahiro Kaneko; Hiroshi Shiratsuchi; Tadayoshi Kaneko
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

5.  A High Triglyceride-Glucose Index Is Associated With Contrast-Induced Acute Kidney Injury in Chinese Patients With Type 2 Diabetes Mellitus.

Authors:  Yuhan Qin; Haixia Tang; Gaoliang Yan; Dong Wang; Yong Qiao; Erfei Luo; Jiantong Hou; Chengchun Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-22       Impact factor: 5.555

6.  Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: a network meta-analysis.

Authors:  Ziwei Mei; Songmei Luo; Peipei Chen; Qiankun Zhang; Limei Zhou; Chaoyong Zhu; Hong Zhu; Lie Jin
Journal:  PeerJ       Date:  2022-02-23       Impact factor: 2.984

7.  Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease.

Authors:  Hao Zhang; Shao-Hua Guo; Zheng-Kai Xue; Ya-Ru Zhang; Jia-Rui Wang; Jing-Jin Che; Tong Liu; Hua-Yue Tao; Guang-Ping Li; Seung-Woon Rha; Swapnil-Zaman Ashraful-Haque; Kang-Yin Chen
Journal:  Clinics (Sao Paulo)       Date:  2021-10-18       Impact factor: 2.365

Review 8.  Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.

Authors:  Aart J van der Molen; Peter Reimer; Ilona A Dekkers; Georg Bongartz; Marie-France Bellin; Michele Bertolotto; Olivier Clement; Gertraud Heinz-Peer; Fulvio Stacul; Judith A W Webb; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2018-02-07       Impact factor: 5.315

9.  Impact of Geriatric Nutritional Index in Contrast-Induced Nephropathy Developed in Patients with Non-ST Segment Elevation Myocardial Infarction who Underwent Percutaneous Coronary Intervention.

Authors:  Mehmet Kucukosmanoglu; Arafat Yildirim; Fethi Yavuz; Mustafa Dogdus; Salih Kilic
Journal:  Medeni Med J       Date:  2020-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.